Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by Yokohama City University Medical Center.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Yasushi Matsuzawa, Yokohama City University Medical Center
ClinicalTrials.gov Identifier:
NCT01484158
First received: November 30, 2011
Last updated: December 1, 2011
Last verified: December 2011
  Purpose

There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).


Condition
Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

Resource links provided by NLM:


Further study details as provided by Yokohama City University Medical Center:

Primary Outcome Measures:
  • Cardiovascular Events [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    cardiovascular death, non-fatal myocardial infarction and non-fatal stroke


Biospecimen Retention:   Samples Without DNA

We retain only blood sample only in this study.


Enrollment: 450
Study Start Date: October 2001
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Myocardial Infarction
Patients with myocardial infarction

Detailed Description:

The investigators will enroll patients capable of walking with STEMI. All patients will receive successful reperfusion therapy within 12-hour from onset. Gait speed during cardiac rehabilitation is measured. Cardiovascular events were defined as a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, for an average follow-up period.

  Eligibility

Ages Eligible for Study:   30 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with acute myocardial infarction.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of ST-segment elevation acute myocardial infarction
  • Must be treated within 12 hours after symptom onset
  • Must be able to walk
  • Must receive successful primary percutaneous coronary intervention

Exclusion Criteria:

  • History of prior myocardial infarction
  • Cerebrovascular disease with residual hemiplegia
  • Severe peripheral arterial disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided by Yokohama City University Medical Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Yasushi Matsuzawa, Primary Investigator, Yokohama City University Medical Center
ClinicalTrials.gov Identifier: NCT01484158     History of Changes
Other Study ID Numbers: Gait Speed Outcome Study
Study First Received: November 30, 2011
Last Updated: December 1, 2011
Health Authority: Japan: Institutional Review Board

Keywords provided by Yokohama City University Medical Center:
Myocardial Infarction

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Cardiovascular Diseases
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases

ClinicalTrials.gov processed this record on October 29, 2014